SCN5A Variant F816Y Detail

We estimate the penetrance of LQTS for SCN5A F816Y around 20% and the Brugada syndrome penetrance around 10%. SCN5A F816Y was found in a total of 3 carriers in 2 papers and/or in gnomAD: 0 had Brugada syndrome, 1 had LQTS. F816Y is not present in gnomAD. F816Y has been functionally characterized in 2 papers. This residue is located in a Mild_Hotspot region for Brugada syndrome and a Mild_Hotspot region for LQTS. In silico predictions, functional data (if available), and location in structure are equivalent to phenotyping 10 individuals for Brugada syndrome (1 diagnosed with Brugada syndrome) and 5 individuals for LQTS (0 with LQTS). These data combined with observations of carriers lead us to estimate the LQTS penetrance for SCN5A F816Y around 20% (1/13) and the Brugada syndrome penetrance around 10% (1/13).

In Silico Data

PROVEAN PolyPhen-2 BLAST-PSSM REVEL Penetrance Density BrS (%) Penetrance Density LQT3 (%)
-2.97 0.993 -1.26 0.976 15 17
PROVEAN scores less than -2 are considered deleterious. REVEL scores higher than 0.5 or 0.75 are considered likely pathogenic (higher sensitivity with the former cutoff, higher specificity with the latter cutoff). A PolyPhen-2 score of 0.85 or greater is considered likely pathogenic. BLAST-PSSM reflects the evolutionary conservation of residue substitutions, more negative numbers indicate fewer observations of the specific substitution than is expected. Penetrance Density is our previously published method to calculate the average BrS/LQTS probability density in a shell of residues surrounding a residue of interest (Kroncke et al. 2019).

Reported Carrier Data

PubMed ID Year Carriers Unaffected LQT3 BrS1 Other Other Disease
27287068 2016 3 0 0 1 RBBB
19716085 2009 1 1 0 0
LITERATURE, COHORT, AND GNOMAD: - 3 2 1 0 -
VARIANT FEATURES ALONE: - 15 14 0 1 - -
Summary totals might not agree with the literature table because of duplicate patients, which were excluded from the total counts. We do not distinguish here between multiple missense codons. Missense variants are combined across degenerate codon substitutions since codon-level data were not consistently available for curation.

Functional Data

Peak and late/persistent current are relative to wildtype (100% being no different from wildtype). V0.5 act/inact are the voltages at which half of the maximal current is reached during an activation and inactivation protocol, each is in units of mV and relative to wildtype.
PubMed ID Year Cell Type Peak Current (%WT) V1/2 Act. (mV) V1/2 Inact. (mV) Late/Persistent Current (%WT)
27287068 2016 Oocytes 120
19716085 2009

F816Y has 60 previously observed neighbors within 15 angstroms

A residue within a folded protein on average has nearest neighbors that fall roughly into two shells: a "nearest" neighbor around 5-6 angstroms and a second shell around 11 angstroms. All variants shown in the rightmost column have been observed in at least one individual in the literature or gnomAD.

Neighbor Distance (Angstroms) Variants Observed in Individuals
723 15 I723V,
811 13 R811H, R811G, c.2435_2436+3delTGGTAinsCGCCT,
821 11
1340 11 V1340I,
1339 13 L1339F, p.L1339del,
1351 12 M1351V, M1351R,
760 14 p.F760SfsX5,
780 12
1452 14
812 7 L812Q,
1350 12 I1350L, I1350T,
792 15
791 14 L791F,
1344 8 F1344L, F1344S,
731 11 T731I,
819 7
826 11 N826D,
818 7
825 9
781 9 W781X,
1348 11 F1348L,
1349 14
822 12 W822C, W822X,
830 15
788 10 I788V,
1346 11 L1346I, L1346P,
833 14 G833R,
724 13 T724I,
782 14 N782T,
1341 14
728 13 V728I,
820 10
810 11
823 14 P823T,
727 11
1456 12
734 12 M734V, c.2201dupT,
827 14
814 9 R814Q,
1460 15 F1460L,
816 0 F816L, F816Y,
813 6 c.2436+12G>A, c.2437-5C>A,
786 14
817 7 K817E,
809 12
815 5
1343 9
1345 14 W1345C,
1342 13
784 8 F784L,
785 11 D785N,
783 14 I783T,
730 13 N730K,
789 14 V789I, V789A,
1347 7
824 13
829 9
787 12
832 12
828 11 L828V,